Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Mar 22, 2017 10:07am
188 Views
Post# 26013115

RE:RE:OVER REACTION

RE:RE:OVER REACTION
37minus4 wrote: Exactly - you guys go all unhinged like a fart in a windstorm. Stag - every so-called fact you're dropping here are creations of your own mind. The fable of Analysts day disaster due to what? Someone's accent, no MOA, deals undone are creations of your imagination. The BLA timeline set in stone was set by you and when it doesn't happen you point at it.

Your frustrated expectations were created by you. Stocks don't go straight up with charts like hockey sticks. Sorry.

33


33, you know I love your work dude... but this time I'm right. Analysts Day was hyped and pumped by the company, delivered exactly NOTHING, and the stock went from $3.20 to $1.50 as a result - I'd call that a complete and utter disaster.

As for this BLA "rolling filing", blah blah blah I work with filing Terabytes of data to the Court, often under nearly impossible deadlines. We do so by planning this filing at the outset. It is ALWAYS done on time. To suggest to me that there is "so much data" doesn't fly. As for my frustrated expectations, I guess when the COMPANY says mid-2017 for Pg launch, and March is almost done and the BLA isn't done being filed yet, and the FDA will take 60 days at minimum, then I guess that's where my expectations come from. Now even RBC is pushing back their expectations.

I love how posters here can look at an RBC downgrade in target price and see a good thing.
Bullboard Posts